Interview with Christian Berk Christian Berk, Ph.D., ETH Zurich How did you become interested in the field of oligonucleotides? Frankly, I did not know much about RNA therapeutics when I joined Jonathan Hall’s group at ETH Zurich. After finishing my studies, I just knew that I wanted to pursue a Ph.D. at the interface…
Science: Q: Paul Zamecnik and Mary Stephenson in 1978 reported the very first studies on antisense mechanisms of gene silencing. Since the inception of this field – how far have we come – both in basic and therapeutic research & development? A: The original antisense mechanism has been joined
Science: Q: Paul Zamecnik and Mary Stephenson in 1978 reported the very first studies on antisense mechanisms of gene silencing. Since the inception of this field – how far have we come – both in basic and therapeutic research & development? A: The original antisense mechanism has been joined
Interview with Marcin Kortylewski …………… Marcin Kortylewski, Ph.D. Associate Professor Department of Immuno-Oncology Beckman Research Institute City of Hope National Medical Center How did you become interested in the field of oligonucleotides? Rather late, after about ten years of graduate and postdoctoral research on signal transduction and tumor immunology in Poland (PUMS), Germany (RWTH)…